Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    HT Staff

    News

    NCCN releases patient guidelines for WM/LPL

    Author:
    HT Staff
    Publish date: February 7, 2017

    The National Comprehensive Cancer Network® (NCCN) has published a set of guidelines for patients with Waldenström’s macroglobulinemia/...

    • Read More

    News

    Azathioprine may increase risk of MDS, AML

    Author:
    HT Staff
    Publish date: February 7, 2017

    Results of a large, retrospective study suggest that taking azathioprine, a drug commonly used to treat autoimmune disease, may increase a person’...

    • Read More

    News

    Therapy demonstrates safety, efficacy in kids with hemophilia B

    Author:
    HT Staff
    Publish date: February 6, 2017

    Photo courtesy of Biogen A recombinant factor IX Fc fusion protein (rFIXFc) has produced favorable results in children with severe hemophilia B,...

    • Read More

    News

    Company reports third death in SL-401 trial

    Author:
    HT Staff
    Publish date: February 4, 2017

    Stemline Therapeutics, Inc.

    • Read More

    News

    Therapy granted PIM designation for CTCL

    Author:
    HT Staff
    Publish date: February 3, 2017

    The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has granted SGX301 (synthetic hypericin) Promising Innovative Medicine (PIM)...

    • Read More

    News

    Kids, parents over-report ALL treatment adherence

    Author:
    HT Staff
    Publish date: February 3, 2017

    New research published in Blood suggests young patients with acute lymphoblastic leukemia (ALL)—and their parents—are likely to over-report...

    • Read More

    News

    Survey reveals misconceptions about FVIII storage

    Author:
    HT Staff
    Publish date: February 3, 2017

    In a survey of 200 adults with hemophilia A, most were not aware that factor VIII (FVIII) products can be stored at room temperature. A majority...

    • Read More

    News

    Gene therapy increases FIX expression in hemophilia B

    Author:
    HT Staff
    Publish date: February 2, 2017

    A gene therapy known as DTX101 has shown early promise for the treatment of adults with hemophilia B, according to the company developing the...

    • Read More

    News

    Cheap manufacture of generic cancer drugs is feasible, study shows

    Author:
    HT Staff
    Publish date: February 2, 2017

    Photo courtesy of FDA AMSTERDAM—New research suggests some generic cancer drugs could be manufactured for less than 1% of the prices currently...

    • Read More

    News

    Company withdraws MAA for pegfilgrastim biosimilar

    Author:
    HT Staff
    Publish date: February 2, 2017

    The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has announced that Sandoz GmbH withdrew its marketing...

    • Read More

    News

    Switzerland to lift lifetime ban on MSM blood donors

    Author:
    HT Staff
    Publish date: February 1, 2017

    The Swiss Agency for Therapeutic Products (Swissmedic) has agreed to lift the ban on blood donations from men who have sex with men (MSM)....

    • Read More

    News

    Recent price hikes for generic cancer meds exceed 100%

    Author:
    HT Staff
    Publish date: February 1, 2017

    AMSTERDAM—The UK has seen substantial price increases for some generic cancer drugs over the last few years, according to a study presented at...

    • Read More

    News

    CHMP recommends hybrid drug for ALL, other disorders

    Author:
    HT Staff
    Publish date: January 31, 2017

    The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for an oral...

    • Read More

    News

    Targeting disease stem cells in AML, MDS

    Author:
    HT Staff
    Publish date: January 31, 2017

    The cell surface molecule CD99 occurs more frequently than normal on stem cells responsible for acute myeloid leukemia (AML) and myelodysplastic...

    • Read More

    News

    Gene therapy granted breakthrough designation to treat hemophilia B

    Author:
    HT Staff
    Publish date: January 31, 2017

    The US Food and Drug Administration (FDA) has granted breakthrough therapy designation for the investigational gene therapy AMT-060 as a treatment...

    • Read More

    Pages

    • « first
    • …
    • 76
    • 77
    • 78
    • 79
    • 80
    • 81
    • 82
    • 83
    • 84
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery